Arecor Therapeutics PLC (AREC) Financial Statements

6 Followers

Arecor Therapeutics PLC Financial Overview

Arecor Therapeutics PLC's market cap is currently £24.92M. The company's EPS TTM is p0.014; its P/E ratio is 2.40; Arecor Therapeutics PLC is scheduled to report earnings on April 13, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	£ 1.71M	£ 5.05M	£ 4.57M	£ 2.40M	£ 1.16M
Gross Profit	£ 1.05M	£ 1.54M	£ 4.57M	£ 2.40M	£ 1.16M
Operating Income	£ -4.60M	£ -10.70M	£ -9.18M	£ -11.66M	£ -5.98M
EBITDA	£ -4.39M	£ -10.15M	£ -8.39M	£ -10.06M	£ -6.27M
Net Income	£ 664.00K	£ -10.24M	£ -8.55M	£ -9.26M	£ -6.17M
Balance Sheet
Cash & Short-Term Investments	£ 6.13M	£ 3.26M	£ 6.75M	£ 12.81M	£ 18.32M
Total Assets	£ 8.10M	£ 8.72M	£ 15.38M	£ 21.77M	£ 20.92M
Total Debt	£ 98.00K	£ 232.00K	£ 338.00K	£ 288.00K	£ 231.00K
Net Debt	£ -2.90M	£ -3.01M	£ -4.75M	£ -4.48M	£ -18.09M
Total Liabilities	£ 1.65M	£ 3.37M	£ 5.85M	£ 4.31M	£ 2.37M
Stockholders' Equity	£ 6.45M	£ 5.35M	£ 9.53M	£ 17.45M	£ 18.55M
Cash Flow
Free Cash Flow	£ -2.39M	£ -9.18M	£ -5.99M	£ -11.13M	£ -5.52M
Operating Cash Flow	£ -2.29M	£ -9.15M	£ -5.84M	£ -10.78M	£ -5.45M
Investing Cash Flow	£ 2.38M	£ 1.72M	£ 6.52M	£ -7.99M	£ -68.00K
Financing Cash Flow	£ -148.00K	£ 5.65M	£ -180.00K	£ 5.16M	£ 20.93M

Currency in GBP

Arecor Therapeutics PLC Earnings and Revenue History

Income Statement >

Arecor Therapeutics PLC Debt to Assets

Balance Sheet >

Arecor Therapeutics PLC Cash Flow

Cash Flow >

Arecor Therapeutics PLC Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >